1. Zhou, Ruihao, Tang, Xiaofeng, Li, Liping, Hu, Haiyan, Lv, Xiao-Bin. 2020. Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma. In Cancer management and research, 12, 531-539. doi:10.2147/CMAR.S232632. https://pubmed.ncbi.nlm.nih.gov/32021462/
2. Gong, Chang, Qu, Shaohua, Lv, Xiao-Bin, Yao, Herui, Song, Erwei. 2014. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. In Nature communications, 5, 5406. doi:10.1038/ncomms6406. https://pubmed.ncbi.nlm.nih.gov/25406648/
3. Cao, Penglong, Zhao, Shuai, Sun, Zhigang, Gu, Juebin, Li, Shijun. 2018. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. In Experimental cell research, 371, 214-221. doi:10.1016/j.yexcr.2018.08.013. https://pubmed.ncbi.nlm.nih.gov/30118697/
4. Lv, Jia, Yang, Huyin, Wang, Xiaodong, Ding, Lianshu, Sun, Xiaoyang. . Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype. In Cancer biomarkers : section A of Disease markers, 22, 311-316. doi:10.3233/CBM-171019. https://pubmed.ncbi.nlm.nih.gov/29660900/
5. Hu, Y, Zhang, Q, Cui, J, Guo, Y-H, Gao, Y-M. . Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L. In European review for medical and pharmacological sciences, 23, 5595-5602. doi:10.26355/eurrev_201907_18293. https://pubmed.ncbi.nlm.nih.gov/31298311/
智鼠故事 
